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ABSTRACT 
The iron status of 76 inner-city adolescent girls aged 12-18 years 
attending Yale-New Haven Hospital Adolescent Clinic and the Hill Health 
Center was investigated employing laboratory tests, chart review, and a 
questionnaire. All subjects were free of inflammatory and chronic dis¬ 
ease. 68% of the subjects were black, 28% Hispanic, and 4% white. Six 
were premenarchal and 5 were utilizing iron supDlements. Two alterna¬ 
tive definitions of iron-deficiency were presented: Criterion 1 (ID-]) 
was a serum ferritin <18 ng/ml and/or a zinc protoporphyrin ^30 ug/dl 
blood, while criterion 2 (ID2) was a serum ferritin <12 ng/ml and/or a 
zinc protoporphyrin >_30yg/dl. 25% and 33% of the 76 subjects met ID2 
and ID-j respectively. 26% and 35% of the postmenarcheal girls who were 
not using iron supplements met Iand ID-j. 11% of 76 and 12% of 65 
subjects had anemia, defined as a hemoglobin <11.5 g/dl, with associat¬ 
ed iron-deficiency. Iron-deficiency was found in all hemoglobin rang¬ 
es (10.0-11.4, 11.5-12.4, 12.4-13.4, and >13.5 g/dl) employing either 
definition. The results of this study were compared to past studies of 
similar design. Over half of the patients with iron-deficiency were 
not identified using the traditional tests of hemoglobin and mean cor¬ 
puscular volume, confronting clinicians with difficult decisions re¬ 
garding the use of iron supplements and further laboratory tests. 
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INTRODUCTION 
The most common cause of anemia during adolescence is iron-defi¬ 
ciency (1). Iron-deficiency anemia (IDA) is particularly common among 
adolescent girls of low socio-economic status (2,3,4). Poor diet and 
increased iron requirements due to puberty and menarche are thought to 
be etiologic factors producing increased susceptibility of teenage fe¬ 
males to IDA. Etiologic factors common to all age groups and both 
sexes include blood loss due to anatomic gut lesions, gastritis, par¬ 
asites, lung disease, epistaxis, kidney disease, and trauma, as well as 
impaired intestinal absorption due to diarrhea, inflammatory bowel dis¬ 
ease, and malabsorption syndrome. 
The production of hemoglobin, and ultimately the vascular trans¬ 
port of oxygen, are dependent upon the supply of iron. Many other 
proteins and enzymes also contain iron, or depend upon the presence of 
iron for their synthesis. It is well known that the decrease in oxy¬ 
gen transport during severe IDA is responsible for various clinical 
signs and symptoms. Iron-deficiency is also thought to result in path¬ 
ophysiologic mechanisms, and subsequent clinical symptoms, due to a 
decrease in other iron-dependent proteins. The extent and importance 
of morbidity in the various organ systems containing these proteins 
are controversial. The degree of iron-deficiency necessary to pro¬ 
duce physiologically relevant tissue changes is unknown. The impor¬ 
tance of subclinical iron-deficiency, or iron-deficiency without anemia 
(sideropenia), is a current topic of debate (5). 
There is no single laboratory test which can determine the pre¬ 
sence and extent of iron-deficiency. Several tests, such as serum 
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ferritin (SF), free erythrocyte protoporphyrin (FEP), transferrin sat¬ 
uration (SAT), serum iron, mean corpuscular volume (MCV), hematocrit 
(Hct), and hemoglobin (Hgb), are available as tools in the diagnosis 
of iron-deficiency. 
There are few studies in which the incidence of IDA has been in¬ 
vestigated among inner-city adolescent girls. In only one study has 
the incidence of iron-deficiency independent of anemia been studied 
in a large population (6). There have not been any studies of sideropen- 
ia and IDA in a socioeconomically and/or racially homogeneous popula¬ 
tion. 
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IRON BIOCHEMISTRY 
Iron is associated with various proteins in all tissues of the 
body. Iron is present in heme containing proteins, non-heme iron- 
containing enzymes, and as an enzyme co-factor(7). 
In heme proteins, iron is bound to a protoporphyrin prosthetic 
group to yield heme. Heme proteins include hemoglobin, myoglobin, 
catalase, peroxidase, and the cytochromes. Hemoglobin is the body's 
oxygen transport protein, while myoglobin stores oxygen in muscle. 
Catalase and peroxidase are involved in peroxide metabolism. Cyto¬ 
chromes a, a^, b, c, c-j, and oxidase are involved in electron trans¬ 
port in the mitochondrion. Cytochromes P450 and b^ are located in 
the endoplasmic reticulum and participate in the degradation of 
drugs and endogenous poisons. 
None-heme enzymes include the iron-sulfur proteins and the met- 
alloflavoproteins. Examples are NADH dehydrogenase, succinic dehy¬ 
drogenase, and xanthine oxidase. 
Iron or heme is required as a cofactor by aconitase and trypto¬ 
phan pyrrolase. Other enzymes which are iron dependent but in 
which the relationship is uncertain include ribonucleotide reduc¬ 
tase anda-glycerophosphate dehydrogenase. Iron may be necessary 
for synthesis of these enzymes or as a co-factor. 
Iron-deficiency has been shown to decrease concentrations of 
many iron containing compounds. The extent of iron-deficiency and 
the tissue involved appear to be important variables in concentra- 
tionreduction. The amount of iron-deficiency necessary to produce 
physiologically relevant reductions in iron containing proteins is 
controversial and yet to be determined. 
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CLINICAL SIGNS AND SYMPTOMS OF IRON-DEFICIENCY 
Dietary disorders in iron-deficiency include anorexia and various 
forms of pica (8), including geophagia and pagophagia (9). Iron-defi¬ 
cient children have been shown to be significantly underweight when com¬ 
pared to normal children (10). Steatorrhea may be a symptom of IDA 
(11). Atrophic glossitis, atrophic gastritis, dysphagia, and esopha¬ 
geal webs are seen in adults with IDA, but are uncommon in children 
(8). 
Central nervous system symptoms include fatigue, irritability, and 
lack of concentrating ability (8). Papilledema may be present in se¬ 
vere IDA. Weakness may be due to a muscular and/or a central nervous 
system basis. 
Cardiovascular symptoms in severe anemia are pallor, palpitation, 
and dyspnea (12). Cardiac enlargement and murmurs may occur (8). 
Skeletal changes may be apparent on roentgenpgraphs of the skull 
and metacarpal bones (8). 
Splenomegally and hepatomegally may occur (12). 
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PATHOPHYSIOLOGY AND MORBIDITY IN IRON-DEFICIENCY 
Cardiovascular and Musculoskeletal Systems 
A decrease in Hgb concentration results in a decrease in the oxygen¬ 
carrying capacity of the blood (8). At very low Hgb concentrations (<7 
g/dl), an increase in cardiac output and heart rate occurs at rest. 
These changes are seen in severe anemias of any etiology. 
In IDA, peak exercise heart rates were significantly increased com¬ 
pared to controls (13). 15% more oxygen was delivered per pulse in iron 
replete than in iron-deficient individuals. However, there was no dif¬ 
ference in oxygen consumption between the two groups. This could be ex¬ 
plained by the increase in heart rate without significant change in 
stroke volume which is seen in exercising individuals with IDA (8). Gard¬ 
ner et al. (13) also found that the iron replete, non-anemic group had 
lower blood lactate levels than the anemic group, both in exercise and 
at rest. 
Studies such as Gardner's have traditionally been used to support 
the concept that impaired maximal physical capacity in IDA is primarily 
due to decreased oxygen-carrying capacity of the blood (8). The other 
factor which may significantly contribute is tissue changes in skeletal 
muscle. Gardner's study suggests that tissue changes have occured, 
since lactate levels are constantly elevated in anemic subjects versus 
controls in the face of equal oxygen consumption. 
Theoretically, one should be able to assess the relative contribut¬ 
ions by doing two studies. In one, iron-deficient, anemic individuals 
would be transfused to Hgb levels equal to that of controls prior to 
exercise testing. Impaired work capacity in the iron-deficient group 
should be due to tissue changes. In the second study, iron replete in¬ 
dividuals would have whole blood removed and replaced with plasma over 
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a short period of time. Exercise capacity would be compared to iron- 
replete controls with normal Hgb, differences being due to oxygen-car¬ 
rying capacity of the blood. 
Finch et al_. (14) performed the first theoretical study in rats. 
Iron-deficient rats were significantly impaired in their running abil¬ 
ity when compared to controls. After 4 days of iron therapy, the im¬ 
pairment was corrected. It was shown that concentrations of myoglobin, 
cytochromes a, a^, b, and c, and rates of oxidative phosphorylation 
with pyrurate-malate, succinate, and a-glycophosphate as substrates 
were reduced in mitochondria from skeletal muscle of iron-deficient 
rats. The only activity which was totally reversed in the 4 days of 
iron therapy was that utilizing a-glycerophosphate. Alpha-glycerophos¬ 
phate is a substrate for a-glycerophosphate dehydrogenase, which is 
necessary for the glycerol phosphate shuttle between the cytosol and 
mitochondria (15). It is thought to be an iron containing protein (14). 
It has been shown by Dallman and Schwartz (16) that the cytochrome c 
and myoglobin of rat skeletal muscle can not be restored after iron de¬ 
ficiency until 40 days of iron therapy. Finch et al_. concluded that a 
decrease in a-glycerophosphate dehydrogenase activity was probably re¬ 
sponsible for the impaired performance. 
A second study (17) showed that iron-deficient rats had increased 
blood lactate levels after exercise when compared to controls. It was 
also shown that lactate infusion into normal animals interfered with 
work performance independently of pH. It was concluded that decreased 
levels of a-glycerophasphate dehydrogenase (oxidase) in iron deficiency 
impairs glycolysis, resulting in excess lactate formation, which in turn 
inhibits physical activity. Glycolysis would be impaired by the decreas¬ 
ed ability to regenerate NAD from NADH in the cytoplasm. 
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Charlton et_ al_. (18) studied cardiac frequency and minute ventila¬ 
tion oyere long period of time on human volunteers made iron-deficient 
by repeated venesection. After being maintained in an anemic state for 
6 to 8 weeks, the subjects were made iron replete by oral iron supple¬ 
mentation. The hemoglobin was kept at a low level by continued venesec¬ 
tion. In one subject, they were able to show a significant change in car¬ 
diac frequency and minute ventilation during work on a treadmill (for 10 
minutes) before and after iron repletion. The Hgb values before and af¬ 
ter iron therapy were not significantly different. No SF, SAT, or FEP 
data were collected to show that the subject was truly iron replete. The 
data did appear to suggest, however, that tissue changes in iron-defi¬ 
ciency significantly impair work performance in humans. 
The authors did not specifically report cardiac frequency or hemo¬ 
globin in these subjects prior to the study. It could be inferred from 
data provided in the report that the subject discussed earlier had a 
cardiac frequency of approximately 105/min. at one treadmill speed, and 
approximately 135/min. at a second, greater speed, prior to venesection. 
While iron replete, with a hemoglobin of 10.7 g/100 ml, the subject had 
cardiac frequencies of approximately 120 and 153 respectively. In that 
subject, the significance of these differences was apparently similar 
to that when he had a constant Hgb of 10.7 g/dl, while iron-deficient 
and replete. Tissue and hemoglobin changes were apparently of approx¬ 
imately equal significance in exercise impairment in thisstudy, although 
it should be repeated in a more rigorous way. 
Rothman et. al_. (19) investigated the effects of iron-deficiency on 
fracture-healing in rats. Chronic iron-deficiency anemia was found to 
greatly prolong non-union and to adversely affect fracture healing as 
determined by tensile strength and histological evaluation. 
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Gastrointestinal Tract 
Dagg et al_. (20) studied cytochrome oxidase activity in the buccal 
epithelium of 21 anemic, 16 sideropenic, and 8 normal subjects. Fifteen 
of the anemic patients, 7 with sideropenia, and none of the normals had 
markedly reduced to absent cytochrome oxidase activity. Cytochrome oxi¬ 
dase activity could not be correlated with the oral changes of atrophic 
glossitis or cheilosis. 
Ghosh ert al_. (21) studied the basal and maximal gastric acid output in 
18 children aged 6-13 years with severe IDA (Hgb<6.0 g/dl, hypochromic micro- 
cyticcells, decreased bone marrow hemosiderin). Mean acidity was significant¬ 
ly reduced when compared with 10 controls (Hgb>13.0). Naiman e^al_. (11) found 
6 of 14 children with IDA to have reduced or absent gastric acidity which did 
not respond to histamine stimulation. 5 of 6 patients showed normal acidity 
after iron therapy. 
Intestinal malabsorption and blood loss in iron-deficiency has been 
investigated by several laboratories. Yeomans and St. John (22) found 
decreased vitamin absorption in iron-deficient rats. Bauerjee et al. 
(23) showed that decreased levels of serum and total folate may be pre¬ 
sent in IDA. 
Kimber and Weintraub (24) studied the absorption of both heme and 
inorganic iron in newly-weaned dogs placed on an iron-deficient diet. In¬ 
itially, iron absorption was increased over controls. With increasing 
severity of iron-deficiency, absorption was decreased below that of con¬ 
trols. 
In mild to moderate IDA in children, iron absorption from the diet 
is usually increased (8, 25). Absorption of iron is impaired in some 
children with IDA (25). Heme iron absorption from the diet is impaired 
in severe IDA (24). In both inorganic and heme iron impairment, absorp¬ 
tion returns to normal with iron repletion. 
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Guha et cfL (12) investigated small bowel function in children aged 
4-12 years with severe IDA. Occult blood in the stool, xylose absorption, 
and stool fat excretion were studied before and after iron therapy. Six 
of 16 with occult blood in their stools, 12 of 17 with an abnormal xylose 
test, and 14 of 18 with increased stool fat before therapy were all found 
to be normal after correction of anemia. Since 23 of the 26 children in¬ 
volved in the study had normal serum albumins, the authors cone!uded that 
the intestinal dysfunction could not be due to protein deficiency. Naiman 
et a]_. (11) studied 14 children under 3 years of age with iron-deficiency 
anemia. Six of 14 showed impaired xylose absorption, 5 of 14 had decreased 
serum carotene, 10 of 14 had abnormal vitamin A tolerance curves, 4 of 14 
showed increased stool fat, and 4 of 14 had positive stool guiac tests. 
Most of these tests returned to normal after iron therapy had corrected 
the anemia. Eight patients with anemia of other etiologies were also 
studied. Vitamin A tolerance and serum carotene were abnormal in these 
patients. Lanzkowsky et aK (27) showed that 6 of 10 children from 8 to 
30 months of age with severe iron-deficiency had impaired lactose toler¬ 
ance. Ghosh et^ al_. (2) were unable to show any significant difference 
in fecal fat excretion or xylose absorption between controls and chil¬ 
dren with iron-deficiency anemia. 
It is apparent that there is a malabsorption syndrome associated 
with iron-deficiency anemia involving vitamin B-^* lactose, iron, and 
probably fats. Some biochemical correlates in the intestinal epithelium 
have been studied (see below). Few studies have been done which show 
that these abnormalities are due specifically to iron-deficiency, and 
not anemia. Whether iron-deficiency anemia is associated with intestinal 
blood loss is less certain. The patients in Naiman's study were ingesting 
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cow's milk on a regular basis. Intake of milk was decreased when iron 
therapy was begun. Intestinal blood loss in iron-deficient infants is 
commonly due to whole cow's milk induced bleeding (26). 
Various enzymes in the intestinal epithelium have been studied in 
iron-deficiency anemia. Lanzkowsky et al_. (27) found that 6 of 10 se¬ 
verely iron-deficient children had abnormal lactose tolerance. Intes¬ 
tinal biopsies were obtained from 5 of these 6. Reduced disaccharidase 
activities (lactase, sucrase, and maltase) were demonstrated in all 5 
samples. Kimber and Weintrab (24) found decreased levels of lactase in 
the internal mucosa of iron-deficient dogs. Intestinal disaccharidases 
are not thought to require iron for activity. Lanzkowsky (27) reports 
that iron-deficiency in rats yields an alteration in the entire protein 
file of polyacrylamide gel scans. He concludes that iron-deficiency al¬ 
ters the protein synthesis mechanism in a quantitative, not qualitative, 
way. 
Dallman and Schwartz (16) showed that the cytochrome C of the in¬ 
testinal mucosa could be reduced 50% by feeding rats an iron-deficient 
diet for 56 days. Correction with oral ferrous sulfate yielded normal 
cytochrome C values in 2 days. Cytochrome oxidase levels were reduced 
with iron-deficiency, and also returned to normal with 2 days of iron 
therapy. Dallman et al_. (28) studied 5 infants with severe iron-defi¬ 
ciencyundergoing intramuscular iron-dextran therapy. In one of those 
patients, a biopsy 24 hours after initiation of therapy showed cells at 
the base of the villi to be darkly stained for cytochrome-oxidase activ¬ 
ity, while those at the tips of the villi were more lightly stained. Af¬ 
ter 72 hours, all cells were darkly stained. Hoensch et al_. (29) stud¬ 
ied the drug-metabolizing (microsomal) enzymes of the intestinal epithel ium 
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in iron-deficient rats. Cytochrome P450 and benzpyrene hydroxylase showed 
significantly decreased activity. Activity was completely restored after 
24 hours by oral iron supplementation, but not by parenteral iron admin¬ 
istration. Lanzkowsky et a]_. (27) reported decreased succinic dehydrogen¬ 
ase activity in 4 of 5 infants with severe iron-deficiency on whom intes¬ 
tinal biopsies were performed. 
In both the rat and man, the lining of the small intestine is re¬ 
placed every two days, while heme protein repair in the intestinal mu¬ 
cosa also takes two days. Dallman et al_. and Hoensch et al_. conclude 
that utilization of iron to produce iron containing enzymes is limited 
to newly-developing intestinal epithelial cells. This idea is sup¬ 
ported by the fact that rates of heme protein repair in red cells and 
muscle parallel known variations in the cell renewal rates of these tis¬ 
sues in the rat (28). Hoensch et al_. further postulate that only iron 
from the intestinal lumen can be utilized. 
Morphological changes in the intestinal mucosa have also been re¬ 
ported in iron-deficiency. Guha et a]_. (12) reported abnormalities in 
11 of 15 patients, including cellular infiltration of the lamina propria, 
fusion, blunting, and atrophy of villi, reduction in the number of villi, 
and atypical villous epithelial cells. Naiman e^ al_. (11) reported sim¬ 
ilar findings in 7 of 11 patients. Both groups reported improvement 
after iron therapy. Ghosh et_ al_. (21) were unable to show significant 
changes in jejunal biopsy specimens from 20 iron-deficient subjects. 
Five infants with severe iron-deficiency anemia studied by Lanzkowsky 
(27) were shown to have normal intestinal mucosa by light and electron 
microscopy. 
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Central Nervous System 
Biochemical Studies 
Dallman et aK (30) investigated non-heme iron content in brains of 
young, iron-deficient rats. Between the 10th and 28th days of life, the 
rats received an iron-deficient diet. The concentration of non-heme brain 
iron was found to be 22% below controls after 28 days. After iron-defi¬ 
cient rats were treated with intra-muscular (IM) iron for 14 to 45 days, 
none-heme brain iron remained depressed at 19-29% below the mean concen¬ 
tration of controls. Brain ferritin also remained depressed at 33-42% 
below control means. The Hct, liver non-heme iron, and liver ferritin 
were severely depressed in iron-deficient rats, but promptly returned 
to control values after treatment. 
Dallman and Schwartz (31) found brain cytochrome C concentrations 
to be resistant to significant decreases in adult rats made iron-defi¬ 
cient Young rats were also resistant (32). Only when pregnant rats were 
made iron-deficient, followed by iron-deprivation of offspring, could 
brain cytochrome C be shown to be significantly lowered. 
Monoamine oxidase (MAO), an enzyme involved in the degradation of 
the neurotransmitters dopamine, norepinephrine (NE), and serotonin, is 
thought to be iron dependent (33). Symes et. al_.(34) investigated liver 
MAO activity in iron-deficient rats. After 5 weeks of iron deprivation, 
liver MAO activity was 18-31% below that of controls. The mean total 
liver iron decreased 64%. Hgb decreased by a ratio similar to that of 
total liver iron. 
Youdim et aK (35) studied human platelet MAO activity in patients 
with Hgb <1Og/dl, MOV <76 fl, decreased serum iron, and decreased SAT. 
MAO activity was significantly reduced 37-52%, depending on the substrate 
used. MAO activity returned to normal in patients receiving oral iron 
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therapy if serum iron levels returned to normal. 
Youdim and Green (36) studied several brain enzymes in rats after 5 
and 9 weeks of iron deprivation. At 5 weeks, there was no decrease in 
brain MAO or aldehyde dehydrogenase activity. At 9 weeks, no decrease 
could be detected in brain tryptophan hydroxylase or succinate deydrogen- 
ase activity, although succinate dehydrogenase activity declined markedly 
in the peripheral tissues of the same animals. Brain MAO activity de¬ 
creased a small but significant 15% after 9 weekscf iron deprivation. Ser¬ 
otonin and catecholamine precursors were administered to control and iron- 
deficient rats. No difference in dopamine or serotonin accumulation was 
noted between the two groups. Subsequent hyperactivity, though, was sig¬ 
nificantly decreased in iron-deficient rats. Youdim and Green concluded 
that a defect might be present in the post-synaptic response of the iron- 
deficient rats, since no pre-synaptic defect could be detected. Whether 
the hyperactivity was a CNS-mediated behavioral effect or one caused by 
peripheral effects of iron-deficiency is difficult to determine. The Hgb 
was reduced to less than one half of that of controls, which may have im¬ 
paired oxygen delivery to peripheral muscle. Decreased levels of skelet¬ 
al muscle enzymes with resultant increases in lactate levels detrimental 
to muscle performance have been demonstrated in iron-deficient rats (14,17). 
Voorhess et a]_. (37) described abnormally high urinary excretion of NE 
in 11 children with Hgb <10.2 g/dl and SAT <15%. After 1 week of iron ther¬ 
apy the NE excretion decreased significantly and returned to a normal lev¬ 
el. All patients corrected their anemia within 6 weeks. Four of 5 ane- 
"iron replete" children showed no significant decrease in NE excre¬ 
tion after transfusion. The authors speculated that increased NE excre¬ 
tion in iron-deficiency could be related to decreased brain MAO degredation 
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of NE. It has been previously noted that symptoms ascribed to iron-defi- 
Ctency, such as irritability and anorexia, are alleviated after a brief 
course of iron-therapy. (38) Voorhess et_ £]_. noted that these symptoms 
disappear during a short period similar to that of the decrease in uri¬ 
nary NE excretion, long before significant increase in Hgb. 
Aldehyde oxidase is an enzyme in the pathway of serotonin degrada¬ 
tion, Mackler et al_. (39) found significantly decreased aldehyde oxidase 
activity in 8 week old rats after 1 month of iron-deprivation. Tbe au¬ 
thors also found increased concentrations of serotonin and 5-hydroxyindole 
compounds. Both findings (enzyme activity and chemical concentrations) 
were in direct contradiction to the results of Youdim and Green (30) dis¬ 
cussed above. One possible reason for the discrepancy could be the age 
of the rats used in the respective laboratories. Youdim and Green do not 
mention the age of their animals, while Mackler e^t al_. used relatively 
young rats. As discussed previously, older rats are more resistant to 
changes in brain cytochrome C induced by iron-deprivation than are youn¬ 
ger rats. 
Behavioral Studies 
Cantwell (40) studied 61 6-7 year old children from similar socio¬ 
economic groups for long-term sequelae of anemia in infancy. Thirty-two 
patients had hemoglobins between 6.1 and 9.5 g/dl between 6-18 months of 
age. Twenty-nine controls who had iron-dextran injections as infants did 
not become anemic as infants. The anemic children had a higher incidence 
of "soft" neurological signs, were less attentive, more hyperactive, and 
scored lower on Binet IQ tests (92 vs. 98) than the controls. No statis¬ 
tical information was given. 
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Oski and Honig (41) studied 24 infants aged 9-26 months with Hgb 
<10.5 g/dl, MCV "<73 f 1, and SAT “<12%. One half the patients received 
iron-dextran injections and the other half received placebo injections 
(controls). All infants were tested on the Bayley Development Scale 
before and after injection. The control group improved 6.1 points on 
the Mental Development Index (not statistically significant) while the 
treatment group improved 13.6 points (statistically significant) in a 
mean time of 6.8 days. The test was wel1-control!ed socioeconomically. 
Sulzer et al_. (42) studied 4 and 5 year old children with Hgb <10.5 
g/dl in a Head-Start program. The anemic group consistently scored sig¬ 
nificantly lower on two IQ tests as well as in an associative learning 
test when compared to controls. 
Webb and Oski (43) investigated scholastic achievement in 92 ane- 
mic(Hgb 10.1-11.4 g/dl) and 101 non-anemic (Hgb 14.0-14.9 g/dl) 12-14 
year old children. Anemic females consistently scored lower than con¬ 
trols at ages 12, 13, and 14 years. Anemic males scored similarly to 
controls at age 12 years, but progressively declined to significantly 
lower scores at ages 13 and 14 years. Conduct disturbances in anemic 
males were reported to be higher than in controls by school teachers 
(44). A signifcantly longer latency in reporting visualization of an af¬ 
ter-image was found in anemic (4.08 seconds) than in non-anemic (1.81 
seconds) subjects. 
The behavioral studies reviewed above have several methodological 
flaws (33), including lack of statistical analysis, inadequate data, and 
lack of documented socioeconomic controls. Webb and Oski mention that 
their findings may be due to poor general (versus iron) nutrition. The 
Bayley Tests are difficult to administer objectively and consistently. 
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Although the preceding studies suggest that IDA is responsible for 
behavioral deficits, they do not differentiate between the effects of 
iron-deficiency and anemia. Two recent studies attempt to investigate 
the effects of isolated iron-deficiency upon infant behavior. 
Deinard et al_. (45) studied 212 infants aged 11-13 months. All in¬ 
fants were described as n on-anemic (Hct >34%). The patients were di¬ 
vided into 3 groups, depending on SF values: SF <9 ng/ml, SF 10-19 ng/ml, 
and SF >20 ng/ml. No statistically significant differences could be 
demonstrated among the 3 groups in cognitive or behavioral function us¬ 
ing the Bayley tests. 
There are several flaws in the design of Deinard's study. Since 
the low-normal limit of SF may be lower among young children than among 
adults (46), the mean value of 8.85 + 1.58 hg/ml for the first group is 
not an impressive standard for "severe iron-depletion," as defined in 
the study. Decreased storage iron, as revealed by SF, is the first 
stage of iron deficiency (47). Decreased storage iron does not neces¬ 
sarily limit the iron which is incorporated into the various iron depen¬ 
dent proteins of the body (including the brain). A much better criterion 
for judging such limitation is an elevated FEP. If the FEP is increased 
the iron supply is limiting the formation of heme. Formation of other 
heme-containing proteins, as well as non-heme iron-dependent proteins, 
is also likely to be limited. Hct is used as a criterion for anemia, 
but is thought to sometimes yield false-high values (47). The study is 
retrospective, an argument often used against past behavioral studies 
with positive results (33). 
Oski et al_. (48) studied 33 infants aged 9-13 months with the Bay- 
ley Mental Development Index (MDI). Ten controls had Hgb >11.0 g/dl, 
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SF >12 ng/ml, FEP <30 yg/dl, and MCV >70 fl. Eight "iron-depleted” infants 
had Hgb >11.0 g/dl, SF <12 ng/dl, FEP <30 yg/dl, and MCV >70 fl. Fifteen 
"iron-deficient" infants had Hgb >11.0 g/dl, SF <12 ng/dl, and FEP 
>30 yg/dl. All subjects were administered the MDI, treated with IM 
iron, and then retested one week later. The mean increases were 7.2 for 
the normals, 3.7 for the iron depleted infants, and 21 for the iron-defic¬ 
ient infants. Only the iron-deficient infants had a statistically signif¬ 
icant increase. 
The effects of iron-deficiency on the nervous system remain contro¬ 
versial. Brain enzymes appear to be resistant to depletion in rats, al¬ 
though reductions in brain enzyme activities may occur in young, develop¬ 
ing rats. The effects of iron-deficiency on brain enzymes in man are un¬ 
known. If parallel to results in rats, iron-deficiency may have impor¬ 
tant .CMS consequences in infants, as suggested by Cantwell and Oski. 
Behavioral studies in iron-deficiency are plagued by poor environ¬ 
mental controls and subjective data-collecting methods. The irritabil¬ 
ity, anorexia, and dietary disorders commonly noted in iron-deficiency 
suggest that there are real effects on the nervous system. The associa¬ 
tion with intel lectual impairment, acute behavioral effects, and long¬ 
term sequelae are yet to be satisfactorily established. 
Physical Growth and Development 
Judisch et al_. (10) studied 88 infants with iron-deficiency ane¬ 
mia (Hgb <.9 g/dl). All infants had low serum iron and decreased trans¬ 
ferrin saturation or a good response to iron therapy. Weight was meas¬ 
ured before and after iron therapy, which was provided until 2 months af¬ 
ter the Hgb returned to normal. Pre-therapy, 15% of the patients were be¬ 
low the 3rd percentile in weight and 60% were below the 50th percentile. 
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Post-therapy, 2% were below the 3rd percentile and 45% were below the 
50th percentile. No statistical analysis was presented. 
Garnand Smith (49) studied data from the 15,000 1-17 year old 
children of the Ten-State Nutrition Survey of 1968-70. The children 
with the top 15% of Hgb values were compared to those with the bottom 
15%. The top 15% were 3 cm. taller at 6 years of age and 3 kg heavier 
until adolescence than the low 15%. Height differences increased af¬ 
ter 6 years of age and weight differences increased during adolescence. 
These differences were true within white and black racial groups. No 
statistical information was given. 
Immunology 
Andelman and Sered (50) studied 1,048 infants of low socioeco¬ 
nomic class, 603 of whom received iron-fortified formula. The group 
receiving the supplemental iron had significantly higher Hgb concen¬ 
trations, as well as a significantly lower incidence of respiratory 
infections. McKay (51) and Salmi et al_. (52) found similar results 
in earlier studies. 
Conolly and Golovsky (53) prospectively studied the relationship 
between wound infection and anemia in surgical patients. Twenty per¬ 
cent of patients with infections had Hgb <10 g/dl, while only 7% of 
patients without infection had Hgb <10 g/dl. 
Cummins et al_. (54) found that rejection of the parasite Nippo- 
strongylus brasiliensis was impaired in rats deficient in both iron 
and protein. Iron-deficiency alone was not studied. 
Fletcher et al_. (55) found that the saliva of patients with atrop- 
ic glossitis and angular chilosis associated with IDA contained more 
Candida than did saliva of controls. The saliva of the IDA patients 
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also supported the growth of Candida more readily. Higgs and Wells (56) 
found that 23 of 31 patients with chronic muco-cutaneous candidiasis were 
iron-deficient. Fifteen of the 23 were sideropenic (decreased serum iron 
reduced or absent bone marrow iron, and Hgb £12.0) and 8 of 23 suffered 
from IDA. Nine of 11 patients treated with iron showed significant clin¬ 
ical improvement. 
Although the studies noted above have suggested an increase in in¬ 
fections in IDA, and possibly in siderpenia as well, other studies have 
failed to show an increase (57). Studies at the cellular and biochemical 
levels have usually supported the idea that immune system function is com 
promised in iron-deficiency. 
Several laboratories have studied lymphocyte transformation follow¬ 
ing phytohemagglutinin stimulation in iron-deficient subjects. Joynson 
et a]_. (58) and Fletcher et al_. (55) showed impaired transformation in 
subjects of various ages with IDA. Srikantia et a]_. (59) and MacDoug- 
a 11 et. aj_. (60) found impaired transformation in children with IDA. Kula- 
pongs et al_.(61) were unable to show any impairment in 8 children with 
IDA, 7 of whom had hookworm infestation. 
Lymphocyte bactericidal function was found to be reduced by sever¬ 
al investigators (59,60,62), but normal in one study (61). Joynson et 
al. (58) found a decrease in migration inhibition factor production in 
IDA. MacDougall et al_. (60) showed increased neutrophil chemotactic acti¬ 
vity. Chandra (62) and MacDougall et al_. studied reduction of nitro- 
blue tetrazolium by neutrophils in subjects with IDA. Chandra found 
reduced activity while Macdougall et. al_. were unable to show an abnor¬ 
mality. Baggs and Miller (63,64) found a direct relationship between the 
amount of myeloperoxidase and dietary iron in rats' small intestine and 
cecum. 
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Nalder et al_. (65) found a direct relationship between the reduc¬ 
tion in dietary iron and the reduction of antibody production in rats. 
Macdougall et_al_.(60) were unable to show a decrease in serum immunoglobu¬ 
lin concentration or salivary IgA in children with IDA. 
Although the relationship between immunocompetence and iron-defi¬ 
ciency remains a matter of debate, there is mounting evidence that there 
is a positive correlation. One can postulate that decreased iron limits 
the production of iron-dependent enzymes, such as myeloperoxidase. Mani¬ 
festations of changes at the biochemical level would be manifested by 
cellular and humoral changes, resulting in an increased incidence and 
severity of infection. 
It is interesting to note that addition of iron to serum in vitro 
as well as intravenous and intramuscular addition of iron in_ vivo have 
been shown to increase the growth of various bacteria in serum (66,67). 
Weinberg's hypothesis of "nutritional immunity"(68) postulates that un¬ 
saturated transferrin is protective against bacterial infection and 
states that iron therapy may reduce resistance by saturating transfer¬ 
rin. However, Pearson et al_. (69) were unable to show any difference in 
rates of growth of E. coli in sera of individuals with SAT from 6-100%. 
The additional iron of other studies may have been added at a rate and 
in quantities that left much of it loosely bound to other serum proteins. 
Such a situation should not occur with oral iron replacement therapy. 
Red Blood Cells and Bone Marrow 
In IDA there is increased destruction of erythrocyte precursors, 
or ineffective erythropoiesis, within the bone marrow (8). DNA and RNA 
synthesis is impaired, and heme production is reduced in normoblasts. 
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There is thought to be a defect in vitamin metabolism which leads 
to hypersegmentation of neutrophils (70). 
Red cell survival is reduced to less than one half of normal due 
to increased hemolysis (8). This destruction occurs only in the pre¬ 
sence of a functional spleen. 
Synthesis of the a and 6 chain subunits of hemoglobin is reduced 
in IDA (8). The a:£-chain ratio is also reduced. 
Macdougall found decreased glutathione peroxidase and catalase 
activities in 15 children with IDA (71). The iron-deficient red cells 
were more susceptible to hydrogen peroxide hemolysis than controls. It 
is thought that the loss of the peroxide detoxifying enzymes may lead 
to oxidative damage to red cell membranes (8). Red cells become less 
deformable after such damage and are more easily trapped by the spleen. 
2,3-DPG, glutamic oxaloacetic transaminase, NADH, and methemo- 
globin reductase activity in red cells are increased in IDA (8). 
It is legitimate to conclude that IDA leads to pathological con¬ 
ditions in several organ systems. Cardiovascular decompensation, im¬ 
paired muscle activity, biochemical, functional, and morphological 
gastrointestinal effects, impaired physical development, cellular im¬ 
mune dysfunction, and biochemical and morphologic erythrocyte alter¬ 
ations are almost definite sequelae of IDA. An increased incidence 
of infections, and behavioral and intellectual impairment must also 
be considered possible results. 
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Little research has been conducted on the physiologic effects of 
sideropenia. Studies have been mentioned reporting decreased cytochrome 
oxidase activity In buccal mucosa, behavioral impairment of infants, and 
increased growth of Candida in saliva in sideropenia. Conclusions regard¬ 
ing the relationship between subclinical iron-deficiency and morbidity 
must await further investigations. 

23 
LABORATORY VALUES IN THE DIAGNOSIS OF IRON-DEFICIENCY 
Although the diagnosis of iron-deficiency depends upon laboratory 
analyses, the determination of a significantly iron depleted state is 
not straightforward. Theoretically, iron-deficiency progresses through 
several stages before the development of anemia (47). In the first 
stage, there are decreased or absent stores of iron in the liver and 
bone marrow, reflected by a decreased concentration of SF. In stage two 
there is a decrease of plasma transport iron, measured by the SAT. In 
stage three the transport iron decreases to an extent that limits the 
production of heme, and FEP levels begin to rise. In the fourth stage, 
there is a detectable decrease in the concentration of Hgb in whole blood 
due to the decrease in heme production. The decrease in Hgb level is of¬ 
ten accompanied by changes in cellular morphology and cell numbers, reflec¬ 
ted by decreased MCV, Hct, and mean corpuscular hemoglobin concentration. 
In individuals, laboratory results often fail to conform to this 
pattern (47). Almost any combination of abnormal and normal laboratory 
values may occur. Some of the reasons will be discussed below. 
Serum Ferritin 
Ferritin is an intracellular iron storage protein found principally 
in the cytoplasm of reticuloendothelial and liver cells (8), but also in 
other tissues, including brain cells (30). The minute amounts of ferri¬ 
tin which are found in serum can be measured by radioimmunoassay. SF le¬ 
vels are thought to reflect the amount of iron stores in the body (72). 
Cook et al_. (73) showed a correlation between SF and iron stores measured 
by radioiron absorption. Luxton et al_. (74) and Mazza et a]_. (75) showed 
a high correlation between low SF and lack of marrow stainable iron. 
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Walters et a]_. (76) found a high correlation between SF concentration and 
storage iron measured by quantitative phlebotomy. Biopsied liver tissue 
has an iron content which can be correlated with SF (77). 
Published low-normal limits (LNL) have varied between 7 and 18 ng/ml, 
depending upon the definition of LNL, age group, and sex. Siimes et al_. 
(46) studied "normal" children between 6 months and 15 years of age with 
Hct 'within 95% confidence limits. They found a median SF concentration 
of 30 ng/ml, and defined the LNL as the 95% confidence limit of 7 ng/ml. 
Six children with "latent iron-deficiency," defined as SAT <16% but with¬ 
out anemia, had a median SF of 10.6 ng/ml with a range of 4.5-51 ng/ml. 
Deinard et a]_. (45) cited Siimes et al_. in defining a SF <_ 9 ng/ml as 
"severely iron-depleted" and a SF from 10-19 ng/ml as "mildly iron de¬ 
pleted." In the original study, many of the "normal" chi 1 dren may have been i ron- 
deficient. The Hgb can be low with a normal Hct (47). No studies, such 
as SAT or FEP, were reported to rule out iron-deficiency independent of 
anemia. 
An often cited study by Cook et_ al_. (73) investigated 326 adults 
from 20-50 years of age with FEP <95 yg/dl, SAT >20%, and Hgb >12 g/dl 
in females and >13 g/dl in males. The LNL was defined as the 95% confi¬ 
dence limit, yielding a value of 9 ng/ml in females and 12 ng/ml for 
the entire sample. 
Lipschitz et al_. (77) found a SF concentration range of 1-14 ng/ml 
in 32 patients with "uncomplicated iron-deficiency" (SAT <16%, TIBC > 
400yg/dl). In 12 other patients with no known systemic disease and 
absent bone marrow hemosiderin, the SF mean was 6 ng/ml with a range of 
1-37 ng/ml. In 8 patients with "diminished" bone marrow hemosiderin. 
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the range was 21-163 ng/ml. In no individual was a value of 20 ng/ml or 
less associated with the presence of stainable iron in the marrow. 
Luxton et_al_. (74) studied 60 women aged 20-49 years and 60 women 
aged 50-79 years. Elimination of patients with evidence of chronic dis¬ 
ease yielded 95% confidence limits of 4-144 ng SF/ml and 9-200 ng/ml 
respectively. A separate group of 248 women undergoing bone marrow as¬ 
pirations were evaluated for bone marrow hemosiderin and SF. The ab¬ 
sence of stainable iron in the bone marrow correlated with SF <18 ng/ml. 
30% of the original 60 women aged 20-49 had no bone marrow iron stores 
using this criterion (comparable to 24% of young college women without 
iron stores in biopsied bone marrow in a study by Scott and Pritchard 
(78)). Using the criterion of Luxton et al_., Mazza et al_. (75) found no 
false-negative values in 19 patients lacking marrow stainable iron who 
were without systemic disease. In 67 patients with various chronic dis¬ 
eases and positive for stainable iron, there were 3 false-positive val¬ 
ues. Cook et al_. (6) studied various laboratory parameters of iron-de¬ 
ficiency in 1564 subjects. 17.5% had FEP >100 ug/dl, 14.2% had SAT < 
15%, 13.5% had SF <12 ng/ml, and 8.3% had Hgb <3rd percentile. Since SF 
is thought to be the first laboratory parameter to become abnormal in 
iron-deficiency, one would expect it to have the greatest incidence of 
low values. A LNL of 12 ng/ml may therefore be too low an estimate. 
Various diseases have been associated with false-negative SF con¬ 
centrations in iron-deficiency. Koerper ert ajh (79) studied patients 
with juvenile rheumatoid arthritis. Many patients with normal or high 
SF responded to iron therapy with increases in Hgb and MCV. None had 
been receiving iron supplements in the previous 6 months. 

26 
Elin et aK (80) injected volunteers with bacterial endotoxin, etio- 
cholanolone, and a control substance to induce fever. 5F levels increased 
significantly for up to 10 days after injection with the pyrogenic com¬ 
pounds. 
Siimes et aK (46) found increased median concentrations of SF in 
children with chronic hemolytic anemias, upper and lower respiratory 
tract infections, fever of unknown origin, gastroenteritis, and acute 
lymphoblastic leukemia. Lipschitz et a]_. (77) found values above the 
upper limit of normal (300 ng/ml cited from Cook et al_. (73)) in inflam¬ 
matory disease, liver disease, and diseases with increased RBC turnover. 
Increased SF levels in hemolytic disease are due to iron overload. 
Increased levels in other diseases may be related to the movement of iron 
into storage compartments, which is thought to occur in infectious dis- 
eases(68). 
SF values increase after only a few days of iron therapy (47). Other 
indices of iron-deficiency, such as FEP, MCV, and Hgb, change much more 
slowly. A seemingly anomalous normal ferritin may therefore be noted 
with a high FEP, low Hgb, and/or low MCV in an iron-deficient individual. 
Free Erythrocyte Protoporphyrin 
The limitation of iron available for incorporation into heme results 
in the accumulation of unused protoporphyrin in normoblasts (8). Dagg et 
al_. (81) studied concentrations of FEP in subjects with iron-deficiency 
anemia (SAT <16%, Hgb <12 g/dl, absence of bone marrow hemosiderin), sid- 
eropenia (SAT <16%, Hgb 12-13 g/dl, absence of marrow hemosiderin), and 
in controls (SAT >16%, Hgb >13 g/dl, presence of normal marrow iron). The 
mean FEP in IDA (160 + 97 yg/dl) was significantly higher than that in 
sideropenia (93 + 60ug/dl), which in turn was significantly higher than 
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that in controls (15.5 +8 yg/dl). The accumulation of FEP was shown to 
be an intermediate stage in the development of IDA. 
The FEP concentration returns to normal only after several months 
of sufficient iron intake (81). Because FEP exists intracellularly, the 
decrease in FEP is thought to depend upon the elimination of old cells 
which were formed during an iron-deficient state. 
The porphyrin present in erythrocytes during iron-deficiency and 
plumbism has been shown to be chelated with zinc (82). The porphyrin 
present in erythropoietic protoporphria was not in the form of zinc pro¬ 
toporphyrin (ZPP). The optimum wave length of light for exciting ZPP 
fluorescence was 423 nm. 
The FEP concentration has traditionally been measured in erythro¬ 
cytes by the use of an acid-extraction method and a fluorometer (83, 84, 
85). The excitation maximum of ZPP was utilized in the development of 
a hematofluorometer (86), a device measuring the ZPP concentration in 
whole blood. The machine was designed to analyze a thin film of blood 
on a disposable glass coverslip. The FEP concentration is reported in 
units of yg per dl packed erythrocytes (pRBC) when determined by the ex¬ 
traction method. The ZPP, as measured by hematofluorometer, is measured 
in yg per dl whole blood. 
Treatment of blood with heparin, EDTA, or oxalate anticoagulants 
does not alter the results of the hematofluorometer (86). Blood may be 
refrigerated in the dark for one week without change in readings. Exten¬ 
sive hemolysis of RBC has little effect on results. 
A universal high-normal limit (HNL) for FEP concentration has not 
yet been established to to poor intralaboratory correlation, even with 
the use of a common method (87). Langer et al. (83) defined 70 yg/dl 
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pRBC as the HNL after studying 20 "normal" men (MCV, SAT, serum iron, and 
Hct within normal limits) with a range of 16-67 yg/dl. McLaren e^t al_. (88) 
found bone marrow hemosiderin to be absent in all patients with FEP >94 
yg/dl pRBC. In a recent review article (89), the HNL is defined as 70 
yg/dl pRBC, 30 yg/dl blood, or 3 yg/g Hgb. In a recent study. Oski et al. 
(48) used ,>30 yg/dl blood as the HNL. Cook et^ al_. (6) used a HNL of 100 
yg/dl pRBC. 
FEP concentrations are thought to be increased in inflammation (47). 
Concentrations are increased in tuberculosis (83). FEP values are moder¬ 
ately to very high in plumbism (82, 90). With the use of a hematofluor- 
ometer, spuriously high results occur in the presence of bilirubin (91), 
with unoxygenated blood (86,91), and with decreasing Hct (86). In sur¬ 
veys comparing extraction and hematofluorometer methods, the latter me¬ 
thod had a low bias(87, 92), although correlation between the methods 
was high. 
Transferrin Saturation and Serum Iron 
Transferrin is an iron-specific transport protein of the body's in¬ 
travascular and extravascular spaces (8). It is synthesized primarily in 
the parenchymal cells of the liver. The SAT is calculated by dividing se¬ 
rum iron concentration by total binding capacity (TIBC) and multiplying 
by 100. TIBC and serum iron are measured spectrophotometrically. 
The LNL of SAT in adults is 16% (47). Between 6 months of age and 
adolescence, the SAT LNL ranges from 7% to 10%. TIBC is usually in the 
vicinity of 200 yg/dl, but may increase to 400 yg/dl or more in iron-de¬ 
ficiency. Serum iron has a LNLfromlO-16 yg/dl. 
Beginning at age 3 years, there are significant diurnal variations 
in serum iron concentrations (93). Because of the high variability of 
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SAT and serum iron with age and time of day, they are better employed 
as confirmatory tests of iron-deficiency than for initial determination. 
Mean Corpuscular Volume (MCV) 
A low MCV is most commonly associated with IDA, thalassemia minor, 
and plumbism. The MCV is measured directly by electron counter. The 
LNL for white non-indigent girls aged 12-13 years is 77 fl, and 78 fl 
for girls aged 14-18 years (95% confidence limits) (94). 
The differentiation among the various etiologies of a low MCV must 
be accomplished through further laboratory analysis (95). Hgb A2 >3.5% 
by quantitative Hgb electrophoresis or microcolumn chromatography estab¬ 
lishes a diagnosis of 6-thalassemia trait. Hgb A >3.5% plus abnormal 
2 
iron status tests usually indicates IDA. A high FEP must be further in¬ 
vestigated for plumbism. A low MCV with Hgb ^^<3.5% and normal iron stud¬ 
ies usually indicates a-thalassemia trait. Alpha-thalassemia may yield 
low Hgb levels independent of superimposed iron-deficiency. To confirm a 
diagnosis of a-thalassemia trait, family genetic studies or restriction 
endonuclease mapping (96) must be performed. 
Alpha-thalassemia is most frequent among Mediterranean ethnic groups 
(95) and Oriental (96) and Black (97) racial groups. The form most often 
found in black Americans is usually of no clinical significance. 29.4% of 
black Americans have a-thalassemia genes, most in the "silent carrier" 
form, as elucidated by restriction endonuclease mapping (97). 
Hematocrit 
The Hct is determined directly by centrifugation or indirectly by 
calculation (MCV x RBC count). The Hct usually equals the Hgb value mul¬ 
tiplied by three using mean values in studies of large populations. In 
anemic individuals, many falsely elevated values are believed to occur. 
For adolescent girls, LNLs of 34% (2) and 35% (98) have been used in pop¬ 
ulation studies. 
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Hemoglobin 
Anemia is usually defined as the decrease in hemoglobin concentrat¬ 
ion and/or total number of RBC below a LNL (8). Anemia develops from a 
variety of etiologies. Blood loss is an important cause. Decreased RBC 
production results from nutritional deficiencies (i.e., vitamin B-j2> f°" 
late, copper, protein, vitamin C, riboflavine, pyridoxine, and iron), 
from bone marrow depression or failure, and from ineffective erythropoi- 
esis. Increased RBC destruction is associated with hereditary diseases 
(e.g., hemoglobinopathies, thalassemias), immune disease, chemical and 
infectious agents, and physical trauma to the erythrocyte. 
Hgb is measured spectrophotometrically after dilution into a solu¬ 
tion which converts it into cyanmethemoglobin. No single LNL is applicable 
to all individuals (47). Normal and abnormal Hgb concentrations have an 
overlap of approximately 2 g/dl. 
Garby et al_. (99) considered IDA to exist in individuals showing a 
significant response in Hct or Hgb following iron therapy. Almost all fe¬ 
male subjects of a Swedish population with a Hct <33% showed a signifi¬ 
cant response, while only 50% of patients with a Hct = 36% responded. 
Subjects with a Hct as high as 41 showed a response. The total frequency 
of response was 17%. In this population, 15% had Hgb <11.5 g/dl and 30% 
had a Hgb <12.0 g/dl. Natvig et_ aj_.( 100) showed that iron therapy may re¬ 
sult in an increase in Hgb value without an increase in Hct. Garby et 
al. do not reveal the frequency of response of Hgb values. Whether or 
not an increase in Hgb or Hct values after iron-therapy occurs only in 
IDA or is physiologically relevant is unknown. If the stated definition 
of IDA is accepted, a Hgb LNL of 11.5 g/dl would have given a good ap¬ 
proximation of the frequency of IDA in the population studied. 
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Natvig et a^. (100) made Hgb determinations in apparently healthy 
Oslo school children. LNLs for girls, based upon 95% confidence limits, 
were suggested to be 11.6 g/dl from 10-13 years and 12.2 g/dl from 14-20 
years. Based upon 95% confidence limits, Dallman and Siimes (94) estab¬ 
lished a LNL of 12.0 g/dl in non-indigent white girls aged 12-18 years. 
Hillman and Smith (4) found high frequencies of anemia in Brooklyn 
using a LNL of 11.0 g/dl in all age groups. Katzman et al_. (98) used a 
LNL of 11.5 g/dl for girls aged 12-15 years in a homogeneously black 
population. In order to validate the definition of anemia utilized, mean 
MCV values were determined for 3 groups. Group one had a Hgb range of 
10.0-10.9, group 2 had a Hgb range of 11.0-11.4, and group three had a 
Hgb range of 14.0 to 14.9. Group three was assumed to contain individuals 
without iron-deficiency. The mean MCV of group three was significantly 
higher than those of groups one and two, which did not differ significant¬ 
ly from each other. 
Dallman et aj_. (101) studied Hgb values of black and white children 
in San Francisco. The two racial groups were controlled for hemoglobino¬ 
pathies, iron-deficiency, thalassemia minor, obesity, and socioeconomic 
status. Median Hgb concentrations in white subjects averaged 0.5 g/dl 
greater than those of black subjects over all ages. In girls aged 10-14 
years, LNL of 12.0 g/dl for white subjects and 11.2 g/dl for black sub¬ 
jects were calculated using 95% confidence limits. Similar differences in 
mean values were described by Owen et_ a]_. (102). Garnet ak (103) found 
median Hgb concentrations in blacks to be 1 gm/dl less than in whites 
from the first through ninths decades of life when analyzing the 1968-70 
Ten-State Nutrition Study. This study was less well controlled than the 
previous two. None of the studies were well controlled socioeconomically, 
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using only gross differences in per-capita income and parents' education 
as indices. No cultural variables, such as diet, were controlled. 
Garn_et al_. (103) studied Hgb values in 39 black and 32 white infants 
from birth through 18 months of age. They were maintained on a supervised 
diet with iron in excess of recommended dietary allowances. There was a 
difference in hemoglobin levels of approximately 0.5 g/dl beginning about 
the fifth month of life, extending to the eighteenth month, when the study 
was terminated. 
The Use of Multiple Laboratory Values in Population Studies 
Dallman et al_. (104) studied 1,128 infants aged 1 year in a U.S. mil¬ 
itary population. Laboratory values were assessed for ability to predict 
response to oral iron therapy. An increase in Hgb 1 g/dl was defined as a 
"physiologically relevant" response. It was determined that in infants 
with Hgb <11.5 g/dl (10th percentile), abnormal SAT, MOV, FEP, and SF were 
poor predictors of response, alone or in combination. Many false-positive 
(non-responders) were identified as iron-deficient. Any method of combin¬ 
ing abnormal tests with low Hgb levels which increased the number of re¬ 
sponders also increased the number of false-positives. If the criteria 
for iron-deficiency was Hgb <11.5 g/dl and at least 1 abnormal value among 
the other 4 tests, approximately 90% of the responders were identified. 
55% of the subjects meeting the criteria did not respond. If Hgb was <11.5 
g/dl and none of 4 tests was abnormal, only 10% of the subjects were re¬ 
sponders. 
The authors' definition of "physiologically relevant" response is 
questionable. Pathophysiological states may exist in sideropenia (see 
above). The response of laboratory tests identifying subclinical iron- 
deficiency may be very relevant but was not considered in the study. 
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Many of the 55% of patients termed "non-responders," who met the criteria 
of low Hgb and at least one other abnormal test, undoubtedly had an in¬ 
crease in SF or a decrease in FEP. 
Cook et al_. (6) measured SF, FEP, SAT, and Hgb in 1 ,564 subjects 
in the state of Washington. Iron-deficiency was defined as 2 or 3 abnor¬ 
mal values among SF, FEP, and SAT. The reason given was that in patients 
with 1 of 3 values abnormal the incidence of anemia as determined by low 
Hgb value was only 10.9%, vs. 8.3% for the entire population. 
Cook et al_. have assumed that the criteria for iron-deficiency is 
the predictability of various laboratory values for low Hgb values. Iron- 
deficiency, though, is well known to exist independently of anemia (47,81). 
Using the authors' definition for iron deficiency, 9.3% of the pop¬ 
ulation was iron-deficient and 4.2% of the population had IDA. 4.8% of ad¬ 
olescent girls had IDA while 10.6% had anemia. It is very unlikely that 
55% of the adolescent girls who had anemia did not have iron-deficiency 
as the etiologic factor, since iron-deficiency is the major cause of ane¬ 
mia in adolescents (1). 
Of the 1,564 subjects, 527, or 34%, had at least 1 of 3 abnormal 
tests among FEP, SAT, and SF. 441, or 28%, had abnormal FEP, SF, or FEP 
and SF. Since SAT is often not a reliable indicator of iron-deficiency 
(47), one might postulate that 28% is an accurate indication of the 
frequency of iron-deficiency in this population. 
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EPIDEMIOLOGICAL STUDIES OF IRON-DEFICIENCY IN ADOLESCENT FEMALES 
Hillman and Smith (4) studied anemia in 5,597 subjects in Brooklyn, 
N.Y., from 1956 to 1965. Black, Puerto Rican, and white females from 10 
to 14 years of age and from 15 years of age and older were considered ane¬ 
mic if the hemoglobin was lower than 11 g/dl. Among black females, 43% 
of 73 from 10 to 14 years and 40.1% of 237 15 years and over were anemic. 
Among Puerto Rican females, 27.3% of 121 from 10-14 years and 35.7% of 
454 15 years and over were anemic. Among white females, 20.5% of 44 from 
10-14 years and 20.1% of 169 15 years and over were anemic. Anemia was 
found to be greater among welfare recipient families than non-recipients 
in most racial and age groups. No statistical studies were performed. 
Pearson et al_. (2) studied 3,000 black subjects living in Gaines¬ 
ville, Florida, between 1964 and 1967. 726 were 10-14 years (males and 
females) and 220 were 14-17 year old non-pregnant females. Anemia was de¬ 
fined as Hct<34%. Anemia was assumed to be due to iron deficiency based 
upon the hypochromic microcytosis of 36 infants with Hct<30% and the re¬ 
sponse to iron therapy of 193 4-6 year old children. 2.6% of the 12-14 
year group and 8.0% of the 14-17 year female group were anemic. 23.9% of 
213 14-17 year pregnant subjects were also found to be anemic. The au¬ 
thors concluded that the!imited ability of adolescent females to respond 
to the increased iron needs of pregnancy indicated marginal reserves of 
iron in that age group. 
Brown et a]_.(3) studied black junior high school students (12-15 
years old) in Philadelphia. The children came from homes of IV and V in 
the Hollinghead Rates of socioeconomic background (105). Of the females 
without G-6-PD deficiency or sickle-cell disease, 117 of 769, or 15.2% 
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had Hgb<TI.5 g/dl. 11.4% at 12 years, 13.2% at 13 years, 17.3% at 14 
years, and 27.3% at 15 years were anemic. Anemia was assumed to be due 
to iron-deficiency due to an association with microcytosis and hypochro¬ 
mia. 
Katzman et al_. (98) studied 1 ,789 individuals at an inner-city HMO 
in New Haven, Connecticut, from 1968-70. 56% were black, 33% were His¬ 
panic, and 11% were white. A Hgb of 12.0 g/dl and Hct of 35% were consi¬ 
dered LNLs for 14-21 year old females. 32.7% of 150 females aged 14-21 
years were considered anemic on the basis of low Hgb values. 13.8% of fe 
males aged 14-21 years had Hct <35%. 11.1% of 72 14-17 year old females 
had Hct <34% (vs. 8.0% in the Gainesville study). The anemia in this 
study was assumed to be due to iron-deficiency based upon study of the 
blood smears. The large discrepancies between the results based on Hct 
and Hgb suggest that the LNL used for Hgb was too high. 
Katzman et al_. also studied interracial differences in the preval¬ 
ence of anemia. Mean Hgb and Hct values were lowest among black females 
in the group aged 14-21 years, followed by Hispanics, and then whites. 
The frequency of anemia in blacks was far higher than in Hispanics and 
whites based upon Hgb (44% vs. 20%) and Hct (20.7% vs. 0%). 
In the preceding studies which compare IDA among racial groups, 
the prevalence may be overestimated among blacks due to potentially dif¬ 
ferent LNLs for Hgb (100, 101, 102). In none of the studies was menstru 
al status determined, nor were patients questioned regarding past iron 
supplementation. Studies relying upon microcytosis and hypchromia as the 
criteria for iron-deficiency may not be accurate due to the high inci¬ 
dence of thalassemia trait among blacks (96, 97). 
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Information concerning sideropenia in large surveys is sparse, par¬ 
ticularly among adolescents. Scott and Pritchard (78) performed bone 
marrow aspiration on 114 white female college students aged 19-25 years 
in Texas during the mid '60s. Stainable iron was totally absent in 24% 
of the subjects. Iron stores were assessed by quantitative phlebotomy 
in 4 subjects who were without bone marrow stainable iron. Iron stores 
averaged 52 mg, equivalent to 68 ml of blood. Two-thirds of the sub¬ 
jects were believed to have less than 350 mg storage iron. 
Cook e^ al_. (6) studied 1 ,564 subjects in the state of Washington. 
The overall racial distribution could not be determined from the data 
presented, although 2% were black and 3% American Indian. 125 were fe¬ 
males aged 12-17 years. Laboratory data for the 125 females were 24.5% 
<12 ng SF/ml, 5.3% >100 mg FEP/dl pRBC, 15.2% <15% SAT, and 10.6% <12 
g Hgb/dl. Iron deficiency was defined as 2 or 3 abnormal values among 
FEP, SAT, and SF. 8.8% were considered iron-deficient. 4.8% were iron- 
deficient and anemic. Since false-low values for SF are seldom found 
(75,77), 8.8% is certainly a low estimate of iron-deficiency in this 
population. 
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PURPOSES AND HYPOTHESES 
In the present study, the iron status of an inner-city population 
of adolescent girls was investigated. In the community studied, most 
of the subjects were of black and Hispanic heritage, and of a homoge¬ 
neous socioeconomic status. Data were obtained by questionnaire, chart 
review, and phlebotomy. 
The incidence of IDA in the study group, as determined by low Hgb 
and MCV values, was expected to be similar to that obtained by other 
authors on similar populations. It was also expected that IDA, as de¬ 
termined by abnormal SF, FEP, and Hgb values, would be equivalent to 
IDA as determined by low Hgb and MCV values. 
The major hypothesis of the study was that the incidence of iron- 
deficiency indicated by abnormal SF and FEP values alone would be sig¬ 
nificantly greater than that discovered with the use of Hgb and MCV 
values alone; in addition to the iron-deficiency anemia detected by 
traditional tests (MCV and Hgb), a significant number of subjects would 
have subclinical iron-deficiency (iron-deficiency in the absence of 
anemia). Because of the high risk of IDA among adolescent girls, a 
significant number of borderline cases were expected to be sideropen¬ 
ic. 
Other objectives included determining the value of using SF, FEP, 
Hgb, and MCV measurements, alone or in combinations, for the detection 
of iron-deficiency and anemia. Comparisons of results were made be¬ 
tween the 2 major racial groups, both within the study and with past 
studies. 
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Subjects were drawn from the Yale-New Haven Hospital (YNHH) Adoles¬ 
cent Clinic and the Hill Health Center, both in New Haven, Connecticut. 
The medical costs of the majority of the patients attending the two cl in 
ics are paid by public agencies. Most live in the inner-city districts 
of New Haven. 
The study was approved by the Human Investigations Committee of 
YNHH and Yale Medical School. Permission to include each subject in 
the study was obtained orally from a patient, or in writing if the pa¬ 
tient attended clinic alone(see Appendix A). 
Most of the subjects were attending clinic for routine physical 
exams. A chart review was performed on each. Patients with evidence 
of blood loss, renal disease, inflammatory disease, lead poisoning, or 
chronic disease were eliminated from the study. The iron status of 76 
patients, aged 12 to 18, was investigated. 
Each subject completed a questionnaire in which information was 
requested regarding age, race, menses, pregnancy, use of iron supple¬ 
ments, and major medical problems (see Appendix B). Two tubes of blood, 
one coagulated and one EDTA anti-coagulated, were obtained from each 
subject. The serum from the coagulated tubes was frozen and stored. 
The anticoagulated samples were stored in the dark at 4° C. 
Electrophoresis was performed on all samples within 1 week on a 
cellulose acetate plate obtained from Helena Laboratories of Beaumont, 
Texas. 
The serum ferritin values were determined by radioimmunoassay using 
the "Fer-Iron" kit obtained from Ramco Laboratories Inc. of Houston, Tex 
as. The method is based upon that of Miles e^t aK (106). The tests 
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were performed in the clinical laboratories of YNHH, where values <12 ng/ml 
are considered abnormal, and values of 12-14 ng/ml are considered "suspi¬ 
cious." 
ZPP values were obtained using a hematofluorometer produced by AVIV 
Associates, model ZPP, using a method based upon that of Blumberg et al. 
(86). Anti-coagulated samples were analyzed within 1 week after storage at 
4 0 C. in the dark. In the YNHH laboratory, a "normal" range is considered 
to be 9-22 ug/dl blood, as determined by eliminating the high and low 51 
of values from samples obtained from medical student volunteers. 
Hgb values were measured with a hemoglobinometer, model number HGBRZ, 
produced by Coulter Electronics. Refrigerated samples were analyzed within 
24 hours, while fresh samples were tested within 4 hours. 
MCV values were obtained by electronic counting with a Coulter counter, 
model number FN. Storage was identical to that of the Hgb samples. 
In all tests of statistical significance, the student's t-test was em¬ 
ployed. 
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RESULTS 
QUESTIONNAIRE RESULTS 
Of the 76 subjects studied, 6 were premenarchal and 5 were using 
iron supplements. The group without menses included 3 blacks, 2 Hispanics, 
and 1 white (Table 1). The age range was 12-14 years, with a mean of 13 
years. The mean SF was 25 ng/ml, the mean ZPP 16 yg/dl, the mean Hgb 
12.6 g/dl, and the mean MCV 83 f1. One subject had an MCV<LLN, none had 
a Hgb >11.5 g/dl, and one had a SF <18 ng/ml. Among the iron supplement 
users were 2 blacks and 3 Hispanics, all of whom were postmenarchal. 
They ranged in age from 13 to 18 years, with a mean of 15 years. Their 
mean SF was 37 ng/ml, the mean ZPP 20 yg/dl, the mean Hgb 13.2 g/dl, and 
the MCV 88 f1. One of the five had a ZPP >30 yg/dl. 
The age ranged from 12 to 18 years, with a mean of 14.7 years for 
the entire study group (Figure 1). After elimination of the 11 subjects 
discussed above, the mean was 14.8 years. 
Of the 76 subjects, 52 (68°/) were black, 21 (28%) Hispanic, and 3 
(4%) white. Of the 65 girls with menses and without oral supplementa¬ 
tion ("subgroup") 47 (72%) were black, 17 (26%) Hispanic, and 1 (2%) white. 
None of the patients were known to be pregnant. Appropriate labor¬ 
atory tests performed in doubtful cases were negative. 
LABORATORY RESULTS 
As noted above, SF values <12 ng/ml are certainly abnormal, while 
values >_12 ng/ml and <18 ng/ml are probably indicative of absent bone mar¬ 
row iron. Of the 76 subjects, 13 (17%) had SF <12 ng/ml and 23 (30%) <18 
ng/ml(Figure 2). Of the subgroup of 65, 13 (20%) had a SF <12 ng/ml and 
22 (34%) <18 ng/ml. Among the 65, the mean SF was 32 ng/ml while the med¬ 
ian was 24 ng/ml. Of the 9 subjects with Hgb <11.5 g/dl, 5 had a SF <12 
ng/ml while 8 had SF <18 ng/ml. 
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Table 1 
Characteristics of premenarchal 
supplement-using groups 
Total number 
Number Hispanic 
Number black 
Number white 
y age (yr) 
y SF (ng/ml) 
y ZPP (yg/dl) 
y Hgb (g/dl) 
y MCV (fl) 
Pre-menarchal 
girls 
6 
1 
3 
2 
13 
25 
16 
12.6 
83 
and iron 
Girls using 
iron supplement 
5 
3 
2 
0 
15 
37 
20 
13.2 
88 
y = mean. 
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Age distribution of all subjects 
Subjects using iron supplement 
Premenarchal subjects 
16 
14 - 
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10 - 
8 - 
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2 - 
12 13 14 15 16 17 18 
Age (years) 
Figure 1 
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ZPP values were analyzed among patients without evidence of iron- 
deficiency (MCV >77f 1, Hgb >_11.5g/dl, SF >J8 ng/ml). As shown in Fig¬ 
ure 3, the mean was 18 and the mode and median were 19 yg/dl. The 
standard deviation was calculated as 4 pg/dl. Since the median, mode, 
and mean were roughly equivalent, a 95% confidence limit of 11-27 yg/dl 
was estimated. Using the method of the YNHH clinical laboratory (90% 
confidence, see above), the normal range was estimated as 12-27 y g/dl. 
A ZPP < 30 y g/dl was considered within normal limits in the present 
study. 
The ZPP values of the group of subjects with MCV >77 fl, Hgb ^11.5 
g/dl, and SF and <18 ng/ml were compared to those of the aforemen- 
ioned group with SF >_18 ng/ml, and determined to be significantly 
(P <0.001) different. The mean ZPP of the group with intermediate SF 
was 30 yg/dl. 
Ten (13%) of the 76 subjects had abnormal ZPP values (Figure 4). 
Nine (14%) of the subgroup of 65 had ZPP ^30 g/dl. The 65 subjects had 
a mean value of 23yg/dl. Four of the 9 subjects with Hgb <11.5 g/dl 
had ZPP >30 g/dl. 
As previously mentioned, several different values have been used 
for the LNL of Hgb. Dallman and Siimes (94) found that the 95% confi¬ 
dence 1 imit for the Hgb of white adolescent girls was 12.0 g/dl. Evidence 
exists that the LNL for the black population should be 0.5 g/dl lower 
(100, 101, 102); a LNL of 11.5 g/dl was used in a study of black females 
by Brown et_ a]_. (3). Brown et al_. presented data that showed signifi¬ 
cant differences between mean MCV values among subjects with Hgb<11.5 
g/dl and iron-replete subjects with Hgb >14.0 g/dl and<14.9 g/dl, sug¬ 
gesting that 11.5 g/dl was a valid LNL. A similar analysis was performed 
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in the present study (see Table 2). Mean SF, ZPP, and MCV were compared 
for the 76 subjects in four Hgb ranges: 1) 10.0-11.4 g/dl, 2) 11.5-11.9 
g/dl, 3) 11.5-12.4 g/dl, and 4) 13.0-14.4 g/dl. Group4was similartothe 
group of subjects receiving iron supplements (see Table 2). The mean MCV for 
groups 1 and 4 were significantly different (P <0.001), but not for group 
1 versus groups 2 and 3. Groups 2 and 4 were also significantly differ¬ 
ent (P <0.01). There were no significant differences among any of the 
groups for ZPP values, although group 1 had a higher mean than the other 
3 groups. SF values were significantly different between groups 1, and 
2, 3 and 4 (P <0.01, 0.01, and 0.05 respectively). SF for groups 2 and 
4 were not significantly different (P >0.6). 25% of the patients in 
group 2 had evidence of iron-deficiency (abnormal SF &/or ZPP), while 89% 
of the patients in group 1 had such evidence. 
The racial heterogeneity of the Hispanic population in the study 
does not allow a label of black or white for purposes of LNL Hgb. The 
mean values for the Hispanic and black subjects without evidence of iron 
deficiency (SF >18 ng/ml, ZPP >30 ug/dl, and MCV >77 f1) were found to 
be 12.9 and 12.8 respectively, a statistically insignificant difference 
(see Table 4). A Hgb LNL of 11.5 g/dl was used for black and Hispanic 
girls, while a LNL of 12.0 g/dl was applied to white subjects. 
The distribution of Hgb values is presented in Figure 5. Seven 
black subjects, 2 Hispanics, and no white subjects were anemic. Nine 
of the total of 76 subjects (12%) and 9 of the subgroup of 65 subjects 
(14%) had Hgb <1X5 g/dl. 
As noted earlier (94), the 95% confidence limits for girls aged 
12-13 years has been calculated at 77 fl, and 78 fl for girls aged 14-18 
years. The distribution of MCV values is presented in Figure 6, Ten sub¬ 
jects, all black, had MCV <77 fl (there were no subjects with an MCV of 
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Table 2 
Comparison by Hgb range of SF, ZPP, and MCV mean values. 
The mean value for each laboratory test in the iron 
supplement-using group is also compared. (See text for 
statistical significance.) 
Group Hgb range y SF (ng/ml) yZPP (yg/dl) y MCV 
1 10.0-11.4 11 24 78 
2 11.5-11.9 35 20 80 
3 11.5-12.4 31 21 83 
4. 13.0-14.4 42 21 89 
iron-sup- 
37 plements^ .3-14.2 (13.2 20 88 
ar. Figure in parentheses : the mean. 
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77 f1). Five had Hgb <11.5, all of whom had other evidence of iron-defi¬ 
ciency (SF<18 ng/ml, and/or ZPP >30 yg/dl). One had a Hgb of 12.0 g/dl, a 
ZPP of 41 y g/dl, a SF of 32 ng/ml, and an MCV of 64 f1. After 1 month of 
iron therapy, the subject had a Hgb of 13.3 and an MCV of 73 f 1. Four 
subjects with abnormal MCV had no evidence of iron-deficiency, at least 
one of whom was found to be refractory to iron therapy. Among the 76 
subjects, 6 of 10 had evidence of iron deficiency. Among the subgroup 
of 65, 6 of 9 had evidence of iron-deficiency. 
Electrophoresis revealed no major hemoglobinopathies among the study 
subjects. Sixty-eight had hemoglobin AA, 4 hemoglobin AS, 2 hemoglobin 
AF, 1 hemoglobin AC., and 1 hemoglobin A? (? = chain with increased mo¬ 
bility. All laboratory iron studies were within normal limits for this 
subject). Quantitative electrophoresis for Hgb A2 was negative for 1 
subject with low MCV and no evidence for iron-deficiency. The others were 
not tested. 
Subjects were analyzed utilizing 2 definitions of iron-deficiency. 
Criterion one for iron deficiency (ID,) was a SF <18 ng/ml or ZPP >30 g/dl 
or both. Criterion two (I) was SF <12 ng/ml or ZPP >_30 ng/dl or both. 
IDA was defined as Hgb <11.5 g/dl plus iron-deficiency as defined above. 
Twenty-three (35%) of the 65 subjects with menses and not employing iron 
supplements met ID-j (see Figure 7). Eight had both abnormal SF and ZPP, 
1 abnormal ZPP only, and 14 abnormal SF only. Eight had Hgb <11.5, yield¬ 
ing 15 (23%) with subclinical iron deficiency. Of the total of 76 sub¬ 
jects, 25 (33%) met ID-j. Seventeen (26%) of 65 subjects met ID2. Both SF 
and ZPP were abnormal in 6, ZPP only in 3, and SF only in 8. Six of 17 
had Hgb <11.5, leaving 11 (17%) with subclinical iron-deficiency. Nineteen 
(25%) of 76 girls met IDg• Two subjects qualifying for IDA employing ID-j 
did not qualify using IDg. although both had MCV suggesting iron-defi- 
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Ciency (MCV of 69 and 70). Therefore, 8 subjects were considered to have 
IDA, translating to 11% of 76 subjects and 12% of 65 subjects. One sub¬ 
ject had a Hgb <11.5 but did not meet ID-j or IDg. 
Table 3 shows the percentage of subjects within various Hgb ranges 
with evidence of iron-deficiency. 89% of girls with Hgb <11.5 g/dl met 
ID-j, while only 67% met ID£. In the Hgb range 11.5-12.4 g/dl, the per¬ 
centages were 35% and 19% respectively. In the subjects with higher Hgb 
values, the percent iron-deficient was essentially constant regardless 
of the criteria employed. The laboratory values of the 47 black and 
17 Hispanic postmenarcha 1 girls free of iron supplements were compared 
(Table 4). Differences in mean values for age, SF, and ZPP were without 
significance. The mean MCV for black girls (84fl) was significantly less 
(P <0.02) than that for Hispanic girls (89fl). The mean Hgb for Hispanic 
girls was 0.4 g/dl greater than that for black girls but not statistically 
significantly different. In subjects without other evidence of iron-de¬ 
ficiency (SF £18 ng/ml, ZPP <30 yg/dl, and MCV >77 f 1), black and Hispan¬ 
ic girls had Hgb of 12.8 g/dl and 12.9 g/dl respectively. In subjects 
with normal Hgb, SF, and ZPP values, mean MCV values were insignificantly 
different between the 2 racial groups. Using ID-j, 47% of Hispanic girls 
and 32% of black girls were iron-deficient. Employing ID^, 41% of Hispanic 
girls and 21% of black girls were iron-deficient. Only 6% of the Hispanic 
subjects had IDA, as opposed to 15% of the black subjects. 
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Table 3 
Comparison by Hgb range of the percent of subjects 
meeting criterion 1 (SF <18 ng/ml &/or ZPP >30 p g/'dl) 
and criterion 2 (SF <12 ng/ml &/or ZPP >30 ug/dl) 
for iron-deficiency 
Hgb range % of subjects, ID-j % of subjects, ID2 
10.0-11.4 89 67 
11.5-12.4 35 19 
12.5-13.4 21 17 
>13.5 17 17 
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Table 4 
Comparison by race of age, hematological test results, 
and statistical significance of differences in values 
u values Hispanic girls 
Age (yr) 15.1 
SF (ng/ml) 33 (24c) 
ZPP (y g/dl) 25 
Hgb (g/dl) 12.7 
Hgba (g/dl) 12.9 
MCV (fl) 89 
MCVb (fl) 89 
% of subjects 
ID1 47 
id9 41 
IDA 6 
black girls probability 
14.6 >0.2 
31 >0.8 
22 >0.1 
12.3 >0.1 
12.8 >0.6 
84 <0.02 
86 >0.2 
32 
21 
15 
aWithout other evidence of iron-deficiency (SF ^18 ng/ml, 
ZPP <30 yg/dl, MCV >LNL). 
bWithout other evidence of iron-deficiency (SF _>18 ng/ml, 
ZPP <30 g/dl, Hgb ill.5 g/dl). 
cFigure in parentheses is the mean if the single distorting 
value of 185 ng/ml is eliminated (see text for explanation). 
ID-j - Iron-deficiency criterion #1 (SF <18 ng/ml &/or ZPP 
3^30 y g/dl). 
ID2 - Iron-deficiency criterion #2 (SF <12 ng/ml &/or ZPP 
>30 y g/dl). 
IDA - Iron-deficiency anemia (meeting criteria of Hgb<11.5 
g/dl and ID-j). 
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DISCUSSION 
The population studied, of uniformly low socioeconomic status, 
would be expected to yield especially high rates of IDA. The high in¬ 
cidence of IDA demonstrated in past studies of adolescent girls was 
confirmed in the present study. 
Past studies have failed to differentiate between menarchal 
and pre-menarchal girls, as well as between those ingesting and not 
using iron supplements. Elimination of the two groups, however, failed 
to create any statistically significant changes in the data. 
The incidence of iron-deficiency determined in any population 
study depends on the laboratory criteria employed. The previously dis¬ 
cussed literature suggests that SF <12 ng/ml is universally accepted 
as abnormal. The intermediate zone >12 ng/ml and <38 ng/ml has been 
associated with absent bone marrow stores of iron, and may be regard¬ 
ed as a "suspicious" zone. Since SF can quickly rise with ingestion 
of iron, 12-17 ng/ml is a borderline range, at the least; a subject 
with SF of 14 may have had a SF of 9 two days earlier. The use of a 
LNL of 18 ng/ml was suggested to be more legitimate by intrastudy ob¬ 
servations. Subjects in the SF range of 12-17 ng/ml had significantly 
greater ZPP values when compared to subjects with SF >18 ng/ml. The 
percent of iron-deficient subjects among subjects with Hgb >12.4 g/dl 
was the same using ID-j and ID2 (Table 3), suggesting that subjects 
who are comparatively iron replete are just as unlikely to have SF 
<18 ng/ml as SF <12 ng/ml. Since high false SF values are much more 
common than low false values (as previously discussed)(75, 77, 79), 
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the use of SF as a criterion for iron-deficiency is unlikely to result 
in an overestimate. 
As discussed above, ZPP values have not yet been standardized among 
different laboratories (87). A value higher than the 95% confidence lim¬ 
it and utilized by previous studies was defined as the HNL. Although 
the correlation between low Hgb and high ZPP was poor (4 high ZPP among 
the anemic subjects), most high ZPP values were associated with low SF 
(Figure 7). In the only case where a high ZPP value was associated with 
a high SF, the MCV and Hgb were found to respond dramatically with iron 
supplementation. 
The statistical significance of the differences in SF between subjects 
with Hgb <11.5 g/dl and al 1 other groups suggests a true difference in iron 
status. A statistically significant microcytosis occurs not only in sub¬ 
jects with Hgb <11.5 g/dl, but also in the 11.5-12.4 g/dl range. The 
percent of subjects with abnormal SF and ZPP is much higher with Hgb 
<11.5 g/dl than in other groups using ID-, or I(Table 3). Employing 
ID?, there is no difference between the Hgb ranges 11.5-12.4 g/dl, 
12.5-13.4 g/dl, and >13.5 g/dl. Employing ID-,, the 11.5-12.4 g/dl 
range is intermediate in percent of iron-deficiency. The significant 
microcytosis in the 11.5-12.4 g/dl group suggests that there is a true 
difference in iron status, in turn suggesting that ID-j is more valid 
than ID2- 
A single Hgb value cannot be used to define anemia in individu¬ 
al cases (47). For the purposes of population studies, a value must 
be found which has approximately equal false-positives and false-neg- 
atives. One of the subjects with Hgb<11.g g/dl had no evidence of 
iron-deficiency (SF of 22 ng/ml, ZPP of 21 yg/dl). One or more sub¬ 
jects with Hgb >_11.5 g/dl may have been anemic. A large number of 
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"non-anemic" subjects had abnormal SF, ZPP, and MCV, and at least 
one responded to iron therapy with an increase in Hgb from 12.0 to 
13.3 g/dl. The number of anemic individuals may have been underesti¬ 
mated. 
Four of the 10 MCV <77 fl were not accompanied by other evidence of 
iron-deficiency. One of the four was shown to have normal amounts of 
Hgb Thalassemia-trait is the most likely etiology for the low MCV 
values. 8% (of 52 black girls) is higher than the expected prevalence 
of thalassemia-trait resulting in decreased MCV (B-thalassemia trait 
0.5-1.0%, a-thalassemia trait 1.9% (96)). Utilization of iron therapy 
and subsequent follow-up might reveal one or more cases of significant 
response in Hgb and MCV values, suggesting undetected IDA. One subject 
was resistant to iron therapy. Follow-up was unavailable in the remain¬ 
ing 3 girls. 
Iron-deficiency was present in 25% to 35% of subjects, depending 
on the criteria used. Subclinical iron-deficiency was present in 17% 
to 23% of the population surveyed. The physiological significance of 
this large percentage is uncertain, as noted above. Only 8% had ZPP 
^30 pg/dl independently of anemia. As previously discussed, limitation 
of heme production, reflected by high ZPP, is more likely to be associat¬ 
ed with limitation of iron-dependent enzyme production than low SF alone. 
One may safely conclude, though, that a large and unacceptable number 
of girls are at risk for the known and postulated pathological conse¬ 
quences of IDA. 
The small sample of Hispanic girls limits the validity of the com¬ 
parison with the black subjects. Iron-deficiency appears to be greater 
in the Hispanics, while IDA is greater among the blacks. This difference 
may be due to a need for a higher Hgb value for defining anemia among 
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Hispanics, although increasing the cut-off to 12.0 g/dl would not in¬ 
crease the percentage of IDA. It may also be due to a greater sus- 
ceptability among blacks to a decrease in Hgb with iron-deficiency. 
Such an explanation could also explain the previously noted difference 
in hemoglobin values between black and white populations (101 , 102, 103). 
In the present study, no significant difference was found in mean Hgb 
of iron-replete black and Hispanic girls (Table 4). 
Katz et al_. (98) studied the same New Haven community in the early 
1970's. A Hgb LNL of 12.0 g/dl was employed. 44% of 77 black females 
aged 14-21 years were found to be anemic. 6.2% of all subjects (Hispan¬ 
ic and black) aged 10-14 years were anemic. In the present study, 27% 
of all 52 black girls had Hgb <12.0 g/dl. 23% of 35 girls aged 14-18 
years and 35% of 17 girls aged 12-13 years had Hgb <12.0 g/dl. The mean 
Hgb of females in the Katz study wasl2.6 g/dl versus 12.4 g/dl in the 
present study, suggesting a smaller statistical deviation in Hgb dis¬ 
tribution in this study. 20.6% of 63 Hispanic females aged 14-21 years 
had Hgb <12.0 g/dl in the earlier study. 14% of the 21 Hispanic girls 
in this Study had Hgb <12.0 g/dl. 
Brown et a!. (3) studied 769 black girls aged 12-15 years in inner- 
city Philadelphia. 15.2% had Hgb <11.5 g/dl, with an overall mean of 
12.5 g/dl. 9% of 34 black girls aged 12-15 years were anemic in the 
present study, with an overall mean of 12.4 g/dl. 13% of 52 black girls 
aged 12-18 were anemic, with an overall mean of 12.4 g/dl. 
The estimated percentage of anemia in the present study is slightly 
lower than that of past studies. This may be due to improved nu¬ 
trition over time, different subject populations, or inadequate sample 
size in the present study. 

60 
Cook et_ aK (6) used a more stringent definition for iron-deficiency, 
as previously noted. 8.8% of girls 12-17 years were found to be iron- 
deficient, with 4.8% IDA. 24.5% had Hgb< 1 2 g/dl, versus 17% in the present 
study. 5.3% had high FEP values, versus 13% in the present study. Using 
I> the percent of adolescent girls with iron-deficiency in the Cook 
study would be similar to that in the present study (25%). Cook, though, 
had a lower percent of low Hgb values (10.6% <12.0 g/dl). The hi gh number 
of abnormal SF values in Cook's study, compared to the present study, may 
to the present study, may be due to the use of a different assay. 
The present study is limited by small sample size, as well as by 
the unavailability of follow-up data after implementation of iron ther¬ 
apy. The population seen in the clinics is likely to be a sample skewed 
from the normal population. They are probably more likely to have had 
adequate past medical care and more likely to have a present illness 
(although patients with known disease were excluded). 
CONCLUSIONS 
The inner-city female adolescent population has a high incidence of 
iron-deficiency, less than half of whom are identified by low Hgb and 
MCV values. The clinical significance of the subclinical iron-defi¬ 
ciency state is unknown, although a few studies have suggested patholog¬ 
ical consequences of sideropenia associated with high FEP values. Analy¬ 
sis of the data in this study suggests that SF values between 12 and 18 
ng/ml may be evidence of significant iron depletion. It is suggested 
that all girls with Hgb values <11.5 g/dl receive iron supplements. 
Girls with Hgb between 11.5 and 12.4 g/dl should be considered for iron 
therapy due to the large percentage of suspected iron-deficiency pres¬ 
ent in this range. 
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APPENDIX A 
You are invited to participate in a study of iron nutrition in teenage girls 
living in New Haven. Many girls of your age do not get enough iron in their diets. 
We are trying to find out how common this lack of iron is in the patients we see 
here. The study involves one needle stick to obtain two small tubes of blood, and 
the completion of a short questionnaire. If it is found that you are not getting 
enough iron, your physician will be notified, and may give you a prescription for 
iron pills. In the study itself, you will be represented by a number and your 
name will not be used in any report. Your results will be entered in your clinic 
chart for use by your doctor. We shall not tell the results to anyone -else without 
your permission. You are free to decide whether or not to participate, and your 
decision will have no effect on your future relationship with the clinic. If any¬ 
thing is unclear, feel free to ask questions before deciding. 
Authorization: I have read the above and decide that........ 
(name of subject) 
vill participate in the project described above. Its general purposes, the 
particulars of involvement and possible hazards and inconveniences have been 
explained to my satisfaction. My signature also indicates that I have received 
a copy of this consent form. 
Signature 
Relationship (self, parent, guardian^ etc.) 
Date 
Signature of Principal investigator Telephone 
or 
Signature of Person obtaining consent Telephone 
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APPENDIX B 
IRON NUTRITION QUESTIONNAIRE 
1. How old are you? _ 
2. What is your race? 
Black | | White | ] Hispanic | ] Other 1 [ 
3. A. Do you have your menstrual period yet? 
Yes ( | No j 1 
B. If yes, how old were you when you first got it? 
C. If yes, do you get your period every month? 
Yes | | No | | 
D. Have you ever been pregnant? Yes 1 | No j | 
E. Are you pregnant now? Yes | | No | [ 
4. Do you take iron pills or vitamins with iron? 
Yes | ) No | 1 
Do you have any important medical problems? 
Yes Q NoQ 
If so, what kind?____ 
5. 
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